William L. Sheppard

William L. Sheppard

Auto-generated profile, based on publicly available information

William L. Sheppard

University of California, Los Angeles

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2025 in Spine
Verified
Journal Article
Closed access
JWJoshua M. Bs Wiener
Joshua M. Bs Wiener
PSParshva A. Bs Sanghvi
Parshva A. Bs Sanghvi
KVKatelyn Bs Vlastaris
Katelyn Bs Vlastaris
TMThomas Mroz
Thomas Mroz
JBJonathan Belding
Jonathan Belding
WSWilliam L. Sheppard
William L. Sheppard
Study Design.: Retrospective cohort study. Objective.: To investigate the relationship between perioperative glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and postoperative outcomes after spinal fusion in obese and diabetic patient populations. Background.: GLP-1 RAs have been shown to be beneficial when used perioperatively in clinical orthopedic arthroplasty literature. Minimal evidence exists showing efficacy with respect to spinal fusion. Materials and Methods.: This retrospective, multi-center study accessed the TriNetX platform, using the research database to identify diabetic patients who underwent spinal fusion between 2008 and 2022. Cohorts were created based on body mass index and GLP-1 RA usage. Propensity score matching was employed to create balanced cohorts utilizing body mass index, hemoglobin A1c, surgical intervention, as well as other demographic characteristics. Orthopedic outcomes were compared between GLP-1 RA users and non-users. The primary outcomes included postoperative infection, readmission, revision surgery, and quality of life metrics. Results.: After matching, the study cohort consisted of 2263 patients, with 1560 classified as obese. GLP-1 RA use was associated with significantly reduced postoperative infection rates [obese: HR = 0.168 (0.086, 0.328), not obese: HR = 0.250 (0.102, 0.612)], fewer revisions [obese: HR = 0.505 (0.368, 0.693), not obese: HR = 0.439 (0.272, 0.708)], decreased postoperative readmission rates [obese: HR = 0.283 (0.243, 0.329), not obese: HR = 0.241 (0.193, 0.301)], and reduced mobility abnormalities [obese: HR = 0.355 (0.230, 0.549), not obese: HR = 0.508 (0.269, 0.959)]. No significant differences were observed in rates of fracture rates between GLP-1 RA users and non-users. Conclusions.: GLP-1 RA use in spinal fusion patients was associated with improved postoperative outcomes, including lower infection rates, fewer revisions, and better quality of life metrics. These findings suggest that GLP-1 RAs may be a valuable adjunctive therapy in managing surgical outcomes in diabetic and obese patients undergoing spinal fusion. Further prospective and animal-based studies are needed to confirm these findings and explore the underlying mechanisms.

7 February 2019 in JCI Insight
Verified
Journal Article
Open access
PDF file
SZStephen D. Zoller
Stephen D. Zoller
HPHoward Y. Park
Howard Y. Park
TOTove Olafsen
Tove Olafsen
CZCharles Zamilpa
Charles Zamilpa
ZBZachary D.C. Burke
Zachary D.C. Burke
NBNicholas M. Bernthal
Nicholas M. Bernthal
Spine implant infections portend disastrous outcomes, as diagnosis is challenging and surgical eradication is at odds with mechanical spinal stability. Current imaging modalities can detect anatomical alterations and anomalies but cannot differentiate between infection and aseptic loosening, diagnose specific pathogens, or delineate the extent of an infection. Herein, a fully human monoclonal antibody 1D9, recognizing the immunodominant staphylococcal antigen A on the surface of Staphylococcus aureus , was assessed as a nuclear and fluorescent imaging probe in a preclinical model of S . aureus spinal implant infection, utilizing bioluminescently labeled bacteria to confirm the specificity and sensitivity of this targeting. Postoperative mice were administered 1D9 probe dual labeled with 89-zirconium ( 89 Zr) and a near infrared dye (NIR680) ( 89 Zr-NIR680-1D9), and PET-CT and in vivo fluorescence and bioluminescence imaging were performed. The 89 Zr-NIR680-1D9 probe accurately diagnosed both acute and subacute implant infection and permitted fluorescent image-guided surgery for selective debridement of infected tissue. Therefore, a single probe could noninvasively diagnose an infection and facilitate image-guided surgery to improve the clinical management of implant infections.

15 January 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HPHoward Y. Park
Howard Y. Park
SZStephen D. Zoller
Stephen D. Zoller
VHVishal Hegde
Vishal Hegde
WSWilliam Sheppard
William Sheppard
ZBZachary Burke
Zachary Burke
NBNicholas M. Bernthal
Nicholas M. Bernthal
Implant-associated infections are challenging to diagnose and treat. Fluorescent probes have been heralded as a technologic advancement that can improve our ability to non-invasively identify infecting organisms, as well as guide the inexact procedure of surgical debridement. This study’s purpose was to compare two fluorescent probes for their ability to localize Staphylococcus aureus biofilm infections on spinal implants utilizing noninvasive optical imaging, then assessing the broader applicability of the more successful probe in other infection animal models. This was followed by real-time, fluorescence image-guided surgery to facilitate debridement of infected tissue. The two probe candidates, a labelled antibiotic that targets peptidoglycan (Vanco-800CW), and the other, a labelled antibody targeting the immunodominant Staphylococcal antigen A (1D9-680), were injected into mice with spine implant infections. Mice were then imaged noninvasively with near infrared fluorescent imaging at wavelengths corresponding to the two probe candidates. Both probes localized to the infection, with the 1D9-680 probe showing greater fidelity over time. The 1D9-680 probe was then tested in mouse models of shoulder implant and allograft infection, demonstrating its broader applicability. Finally, an image-guided surgery system which superimposes fluorescent signals over analog, real-time, tissue images was employed to facilitate debridement of fluorescent-labelled bacteria.

19 June 2025 in Journal of Bone and Joint Surgery
Verified
Journal Article
Open access
CHChristopher David Hamad
Christopher David Hamad
WSWilliam L. Sheppard
William L. Sheppard
RCRene Chun
Rene Chun
ZMZara Mamouei
Zara Mamouei
TLTrevor S. Lloyd
Trevor S. Lloyd
EMEdward J McPherson
Edward J McPherson
Background: Implant-associated infections (IAIs) require aggressive debridement to eliminate microbial bioburden. The use of irrigants may improve microbial killing during debridement. This study compared the efficacy of surgical irrigants in vitro against Staphylococcus aureus alone and in combination with Candida albicans, in both planktonic and biofilm states. Methods: Full-strength Dakin’s solution, 0.35% povidone-iodine (PI), 10% PI, 3% hydrogen peroxide (HP), a 1:1 combination of 10% PI and 3% HP (PI + HP), Irrisept, XPERIENCE, Bactisure, and normal saline solution were tested. For planktonic testing, 1 × 106 colony-forming units (CFUs) of S. aureus and C. albicans were utilized, and biofilms were grown in these conditions on 0.8 × 10-mm titanium alloy Kirschner wires for 48 hours. Killing assays were performed using 5-minute dwell times. Success was defined by complete eradication of planktonic or biofilm CFUs. Results: PI + HP and Bactisure were the only irrigants to eradicate S. aureus in both planktonic and biofilm states. PI + HP was the only irrigant to eradicate polymicrobial S. aureus + C. albicans bioburden in both states. Conclusions: PI + HP and Bactisure were superior irrigants against S. aureus, eliminating it in planktonic and biofilm states. PI + HP was the only irrigant to eradicate polymicrobial S. aureus + C. albicans bioburden in both states. In vivo studies are needed to evaluate the clinical effectiveness. Clinical Relevance: Surgical irrigants have variable efficacy in eradicating microbes depending on their state of existence (planktonic versus biofilm). In this study, the most effective eradication of polymicrobial S. aureus + C. albicans bioburden was a 1:1 combination of 10% PI and 3% HP, which is of nominal cost.

22 February 2021 in The Journal of Knee Surgery
Verified
Journal Article
Closed access
PDF file
WSWilliam L. Sheppard
William L. Sheppard
AUAlexander Upfill-Brown
Alexander Upfill-Brown
KMKevin M. McKay
Kevin M. McKay
HPHoward Y. Park
Howard Y. Park
ASAkash Shah
Akash Shah
ASAdam A. Sassoon
Adam A. Sassoon
There is currently a paucity of data regarding the potential relationships between preexisting spinal deformity and clinical outcomes following total knee arthroplasty (TKA). We sought to expand upon this deficit. We hypothesize that lumbar sagittal mismatch deformity (MD) will correlate with a decrease in functional outcomes after TKA. This retrospective cohort comparison of 933 TKAs was performed between January 2017 and 2020. TKAs were excluded if they were not performed for primary osteoarthritis (OA) or if preoperative lumbar radiographs were unavailable/inadequate to measure sagittal parameters of interest: pelvic incidence, sacral slope, pelvic tilt, lumbar lordosis, and deformity mismatch. Ninety-four TKAs were subsequently available for inclusion and divided into two groups: those with MD as defined by |PI-LL| > 10 degrees and those without MD. The following clinical outcomes were compared between the groups: total postoperative arc of motion (AOM), incidence of flexion contracture, and need for manipulation under anesthesia (MUA). In total, 53 TKAs met the MD criteria, while 41 did not have MD. There were no significant differences in demographics, body mass index, preoperative knee range of motion (ROM), preoperative AOM, or opiate use between the groups. TKAs with MD were more likely to have MUA (p = 0.026), ROM <0 to 120 (p < 0.001), a decreased AOM by 16 degrees (p < 0.001), and a flexion contracture postoperatively (p = 0.01). Preexisting MD may adversely affect clinical results following TKA. Statistically and clinically significant decreases in postoperative ROM/AOM, increased likelihood of flexion contracture, and increased need for MUA were all noted in those with MD. This is a Level 3 study.

19 June 2023 in Clinical Spine Surgery
Verified
Journal Article
Closed access
GFGaylinn Kwame Md Firempong
Gaylinn Kwame Md Firempong
WSWilliam L. Sheppard
William L. Sheppard
YGYaroslav Gelfand
Yaroslav Gelfand
BEBenjamin M. Ellingson
Benjamin M. Ellingson
LHLangston T. Holly
Langston T. Holly
Study Design: Prospective single institutional cohort study on degenerative cervical myelopathy (DCM) from 2009 to 2022. Objective: This study aims to assess the relationship among preoperative spinal cord signal change, postoperative signal change evolution, and functional outcome in patients undergoing surgery for DCM. Summary of Background Data: There is conflicting evidence on whether spinal cord signal intensity influences functional outcomes in patients with DCM. Patients and Methods: This prospective study investigated 104 patients with DCM that underwent both preoperative and routine postoperative cervical spine magnetic resonance imaging (MRI) as part of a research protocol. Signal intensity/grade, modified Japanese Orthopedic Association (mJOA) scores, signal resolution, and patient demographics were assessed. Results: Sixty-eight of the subjects were found to have abnormal T2 spinal cord signal intensity changes on their preoperative MRI. The total mean preoperative mJOA score was 13.6, increasing postoperatively to 16 (P < 0.001). The presence or absence of preoperative spinal cord signal change was not associated with the change in mJOA score or neurological recovery rate after surgery. Of the 68 patients with preoperative T2 signal change, 36 were found to have an improvement in the T2-weighted signal grade after surgery and 32 had no change in postoperative signal grade. The mean improvement in mJOA score (3.7) and neurological recovery rate (70.3%) was significantly higher in the patients with preoperative signal change whose postoperative MRI signal change grade improved by at least one point compared with those that did not (2.0, 50.5%), (P < 0.001, P < 0.003). Conclusions: The presence of preoperative T2-weighted signal change was associated with lower preoperative mJOA scores, but no change in mJOA after surgery or postoperative neurological recovery rate. However, improvement in T2-weighted spinal cord signal grade on postoperative MRI was significantly associated with a degree of neurological improvement after surgery.